The increase of serum FGF21 in patients with severe AP was weaker than that of patients with mild AP, and the expression of Sirt1 was not substantial, suggesting that FGF21 may have a potential regulatory effect on Sirt1 in patients with AP. The gene discussed is FGF21; the disease is alkaline phosphatase measurement.